ZOLEDRONIC ACID

Peak

zoledronic acid

NDAINTRAVENOUSSOLUTION
Approved
Dec 2015
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
20

Clinical Trials (5)

NCT05080790Phase 2Completed

Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Leiomyosarcoma

Started Nov 2021
7 enrolled
Leiomyosarcoma
NCT04325776Phase 2Unknown

A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis

Started Sep 2020
NCT03812367N/AWithdrawn

Activity of Pre-Osteoclasts and Osteoclasts Over Time in Postmenopausal Women Treated With Denosumab or Zoledronic Acid

Started Jan 2019
0
Osteoporosis, Postmenopausal
NCT03087851Phase 4Completed

Treatment With Zoledronic Acid Subsequent to Denosumab in Osteoporosis

Started Mar 2017
61 enrolled
Osteoporosis
NCT02516423Phase 3Unknown

Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone

Started Dec 2015
11 enrolled
Solitary Osseous Plasmacytoma